近日，北京律师张晓玲称“在爱康国宾体检10年未能查出患癌风险”一事引发广泛关注。
A dispute between a Beijing lawyer and one of China's largest private health screening providers, iKang Guobin Healthcare Group, has ignited a heated public debate over the reliability of commercial medical check-ups in detecting serious illnesses.
The controversy began when Zhang Xiaoling, a practicing lawyer in Beijing, publicly accused iKang Guobin of failing to identify her cancer risk through annual physical examinations conducted over the past decade.
7月30日上午，爱康国宾召开“媒体说明会”。
爱康国宾相关负责人介绍了张女士在爱康近十年体检的经过，该负责人称张女士的体检十年均为北京律师协会提供的福利基础套餐。除2017年外，张女士没有自费购买任何特色/升级项目。
In response, iKang Guobin held a press conference on Wednesday to present its defense. Company executives revealed that Zhang had consistently opted for basic check-up packages subsidized by the Beijing Lawyers Association (BLA) throughout her ten years as a client, with only one optional upgrade in 2017.
据介绍：
张女士2023年10月9日在北京爱康国宾西内门诊部参加健康体检，体检结果显示有肾错构瘤可能，爱康国宾建议“首次发现者需要做CT，以除外其他肾脏占位性病变”，“以除外其他肾脏占位性病变”即是提示癌症可能性。
会上，爱康国宾还公布了张女士2023年10月9日在北京爱康国宾西内门诊部参加体检的部分报告，其中专家建议与指导部分显示：肾钙化灶和肾错构瘤可能。
The company displayed her 2023 medical report, which noted a suspected renal hamartoma and explicitly recommended further CT scans to rule out malignancies—a suggestion they claimed she did not pursue.
该负责人称，不存在健康爱康体检没查出来异常，而其他机构就查出来的情况；根据现有的公开信息，北京大学国际医院病理报告明确标注张女士是早期肾癌，而不是其自述的晚期。
The company strongly denied allegations of negligence, citing a Peking University Internatoinal Hospital pathology report that classified Zhang's condition as early-stage kidney cancer rather than the advanced case she described.
爱康集团资深副总裁周晓江宣布，已向法院提起诉讼，法院已正式立案受理。爱康集团董事长张黎刚表示，为了维护爱康15000名员工的尊严，为了给行业正名，爱康不得不做出这个非常艰难的决定。
Zhou Xiaojiang, iKang's senior vice president, announced the company had filed a defamation lawsuit against Zhang to "protect the reputation of its 15,000 employees" and "clarify industry standards."
张晓玲发声：未收到起诉
7月30日，当事人张晓玲律师再发博，称未收到起诉内容。
Zhang later countered on social media that she had not been served any legal documents.
在说明会前一天，张晓玲通过微博发布了爱康国宾“北京媒体见面会”10个谎言，称自己不出意外地被排除出邀请名单之列。她将征集20名关于体检行业漏诊、误诊行为的维权律师团队，并在全国征集1万名爱康国宾体检受害人的典型案例，正式发起公益诉讼，推动中国体检医疗行业的立法完善。
The case has sparked broader discussions about the role and limitations of private health screenings. Zhang has pledged to form a legal team to pursue collective action on behalf of what she describes as victims of iKang's services, with the long-term goal of pushing for legislative reforms in China’s medical check-up industry.
据此前报道，7月17日，北京执业律师张晓玲表示，自己在爱康国宾做了10年体检，但体检报告始终无癌症预警。2024年，她被诊断出右肾癌症；2025年，癌细胞伴随骨转移。张晓玲质疑爱康国宾多年来实施假体检，并向该机构发律师函。
Zhang, who was diagnosed with kidney cancer in 2024 and later found to have bone metastases in 2025, claimed the company had provided "fake check-ups".
爱康国宾CEO一句话引发热议
在发布会上，爱康集团创始人、董事长兼CEO张黎刚称：“当你指望说，一个几百块钱的体检能帮你什么病都查出来，而要查单一的病，多花几千几万块钱的时候，你认为这样的情况存在吗？”
“至于（大众对于体检理解）这样模糊的原因，就是因为我们公众对于体检与看病，没有明确的边界，导致公众对体检有很多误解。”
Meanwhile, iKang CEO Zhang Ligang emphasized that basic check-ups should not be mistaken for comprehensive diagnostics. "Expecting a routine physical exam costing a few hundred yuan to detect all potential diseases is medically unrealistic," he stated during the press conference.
发布会上，张黎刚还提到，体检还不能预测所有的癌症，也无法取代专科医生来看病，体检的意义在于通过科学的检查项目，帮助其发现身体可能的警报信号，然后给出进一步诊断的建议，及时去找专科医生做更为深入的检查。
相关言论一出引发不少网友热议：
爱康国宾官方账户则在评论区留言：
据澎湃新闻评论称，事实上，为了营销，各种体检机构可能会有意无意夸大体检对于疾病早发现的效果，这其实为后续产生矛盾埋下了隐患。
说到底，体检机构应该让大家知道，健康体检是一种过滤式的筛查，可以发现一些早期疾病，但不是发现早期疾病的“万能保险”，大家对健康体检不要期望过高。
Industry observers note the controversy reflects growing public skepticism toward private healthcare providers, many of which have been accused of overstating the effectiveness of early detection services in marketing campaigns.
此外，体检的质量标准也要跟上，包括体检结果的综合评估、体检套餐的合理搭配等。前端设计明了，消费者才能知道自己选择的体检，到底能带给自己什么。
Legal experts suggest the case could set important precedents for consumer rights and corporate accountability in China's rapidly expanding preventive healthcare sector.
你怎么看？
来源：中国青年报 澎湃新闻 东方财经 读秒财经等
China Daily精读计划
每天20分钟，英语全面提升！
热门跟贴